1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-06-30 pm EDT
3.660 CAD   -18.49%
05:31pCanopy Growth Announces Additional Exchanges with Holders of Notes
PR
05:25pTSX tumbles nearly 14% in second quarter amid recession fears
RE
12:48pPiper Sandler Lowers Canopy Growth's Target to US$3, Says Sales to Remain Pressured
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/24/2022 06/27/2022 06/28/2022 06/29/2022 06/30/2022 Date
4.88(c) 4.89(c) 4.64(c) 4.49(c) 3.66(c) Last
1 078 953 1 210 122 1 154 336 982 908 3 682 142 Volume
+4.27% +0.20% -5.11% -3.23% -18.49% Change
More quotes
Estimated financial data (e)
Sales 2023 523 M 406 M 406 M
Net income 2023 -418 M -324 M -324 M
Net Debt 2023 451 M 350 M 350 M
P/E ratio 2023 -3,39x
Yield 2023 -
Sales 2024 688 M 535 M 535 M
Net income 2024 -314 M -244 M -244 M
Net Debt 2024 652 M 506 M 506 M
P/E ratio 2024 -4,69x
Yield 2024 -
Capitalization 1 474 M 1 145 M 1 145 M
EV / Sales 2023 3,68x
EV / Sales 2024 3,09x
Nbr of Employees 3 151
Free-Float 64,6%
More Financials
Company
Canopy Growth Corporation is a Canada-based diversified cannabis, hemp, and cannabis device company, which offers a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada. The Company operates through two segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the... 
Sector
Pharmaceuticals
Calendar
08/09Earnings Release
More about the company
Ratings of Canopy Growth Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about CANOPY GROWTH CORPORATION
05:31pCanopy Growth Announces Additional Exchanges with Holders of Notes
PR
05:25pTSX tumbles nearly 14% in second quarter amid recession fears
RE
12:48pPiper Sandler Lowers Canopy Growth's Target to US$3, Says Sales to Remain Pressured
MT
10:03aCanopy Growth Declines 20%, CIBC Lowers Price Target
MT
09:55aConstellation Brands' Fiscal First-Quarter Results Top Estimates; Proposes to Overhaul ..
MT
09:44aUPDATE ON CANOPY GROWTH : Down 20% to 52 Week Lows On TSX After Detailing Exchanges with H..
MT
09:01aCanopy Growth Celebrates Summer with New 'Just Hits Different' Beverage Campaign
PR
07:58aCanopy Growth to exchange C$262.7M in notes for shares and a bit of cash
AQ
07:57aConstellation Brands 1Q Sales Rise on Demand For Beer
DJ
06:54aCanopy Growth Down 7% In US Pre-Market After Detailing Exchanges with Holders of Near U..
MT
06:10aPiper Sandler Adjusts Canopy Growth's Price Target to $3 From $4, Reiterates Underweigh..
MT
06/29Canopy Growth Announces Exchanges with Holders of Approximately US$198 Million of Conve..
PR
06/28Fitch Downgrades Canopy's IDR to 'CCC'
AQ
06/27Constellation Brands to See Strong Beer Topline Trends in Fiscal Q1, RBC Says
MT
06/27Constellation Brands Poised for Fiscal First-Quarter Beat, Could Raise 2023 Earnings Ou..
MT
More news
News in other languages on CANOPY GROWTH CORPORATION
12:48pPiper Sandler abaisse l'objectif de Canopy Growth à 3 $ US, et affirme que les ventes r..
09:55aLes résultats du premier trimestre fiscal de Constellation Brands dépassent les estimat..
09:44aMISE À JOUR SUR CANOPY GROWTH : Baisse de 20 % à son plus bas niveau sur 52 semaines à la ..
08:55aCONSTELLATION BRANDS : bat le consensus mais réduit ses prévisions à cause du cannabis
07:33aLAUTERBACH : Cannabis-Freigabe mit dem Prinzip 'Safety first'
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 21
Last Close Price 3,66 CAD
Average target price 7,19 CAD
Spread / Average Target 96,5%
EPS Revisions
Managers and Directors
David Eric Klein Chief Executive Officer & Non-Independent Director
Judy Hong Chief Financial Officer & VP-Investor Relations
Judy A. Schmeling Chairman
Mark A. Ware Chief Medical Officer
Jonathan Di Tosto Chief Operating Officer